These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17077940)

  • 41. Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients.
    Petrie KA; Lee WH; Bullock AN; Pointon JJ; Smith R; Russell RG; Brown MA; Wordsworth BP; Triffitt JT
    PLoS One; 2009; 4(3):e5005. PubMed ID: 19330033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibrodysplasia ossificans progressiva in a newborn with cardiac involvement.
    Marseglia L; D'Angelo G; Manti S; Manganaro A; Calabrò MP; Salpietro C; Gitto E
    Pediatr Int; 2015 Aug; 57(4):719-21. PubMed ID: 25809395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrodysplasia ossificans progressiva in a young adult with genetic mutation: Case report.
    Wang Z; Wang X; Liu B; Hou Y
    Medicine (Baltimore); 2021 Mar; 100(9):e24620. PubMed ID: 33655926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early diagnosis of fibrodysplasia ossificans progressiva.
    Kaplan FS; Xu M; Glaser DL; Collins F; Connor M; Kitterman J; Sillence D; Zackai E; Ravitsky V; Zasloff M; Ganguly A; Shore EM
    Pediatrics; 2008 May; 121(5):e1295-300. PubMed ID: 18450872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrodysplasia ossificans progressiva in Spain: epidemiological, clinical, and genetic aspects.
    Morales-Piga A; Bachiller-Corral J; Trujillo-Tiebas MJ; Villaverde-Hueso A; Gamir-Gamir ML; Alonso-Ferreira V; Vázquez-Díaz M; Posada de la Paz M; Ayuso-García C
    Bone; 2012 Oct; 51(4):748-55. PubMed ID: 22796417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.
    Gregson CL; Hollingworth P; Williams M; Petrie KA; Bullock AN; Brown MA; Tobias JH; Triffitt JT
    Bone; 2011 Mar; 48(3):654-8. PubMed ID: 21044902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional modeling of the ACVR1 (R206H) mutation in FOP.
    Groppe JC; Shore EM; Kaplan FS
    Clin Orthop Relat Res; 2007 Sep; 462():87-92. PubMed ID: 17572636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva.
    Takahashi M; Katagiri T; Furuya H; Hohjoh H
    Gene Ther; 2012 Jul; 19(7):781-5. PubMed ID: 22130450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva.
    Cai J; Orlova VV; Cai X; Eekhoff EMW; Zhang K; Pei D; Pan G; Mummery CL; Ten Dijke P
    Stem Cell Reports; 2015 Dec; 5(6):963-970. PubMed ID: 26626181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A fibrodysplasia ossificans progressiva patient with a rare missense mutation in ACVR1 detected on
    Ni H; Tang S; Zhang Y
    Joint Bone Spine; 2024 Mar; 91(2):105682. PubMed ID: 38159793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a.
    Song H; Wang Q; Wen J; Liu S; Gao X; Cheng J; Zhang D
    Int J Mol Sci; 2012; 13(2):2063-2077. PubMed ID: 22408438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrodysplasia ossificans progressiva: three Indian patients with mutation in the ACVR1 gene.
    Shukla A; Taywade O; Stephen J; Gupta D; Phadke SR
    Indian J Pediatr; 2014 Jun; 81(6):617-9. PubMed ID: 23918320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new mutation of the noggin gene in a French Fibrodysplasia ossificans progressiva (FOP) family.
    Fontaine K; Sémonin O; Legarde JP; Lenoir G; Lucotte G
    Genet Couns; 2005; 16(2):149-54. PubMed ID: 16080294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrodysplasia ossificans progressiva as a form of pseudodystonia.
    Dulski J; Sławek J
    Parkinsonism Relat Disord; 2020 Aug; 77():180-181. PubMed ID: 32046912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and characterization of regulatory elements in the promoter of ACVR1, the gene mutated in Fibrodysplasia Ossificans Progressiva.
    Giacopelli F; Cappato S; Tonachini L; Mura M; Di Lascio S; Fornasari D; Ravazzolo R; Bocciardi R
    Orphanet J Rare Dis; 2013 Sep; 8():145. PubMed ID: 24047559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis.
    Kaplan FS; Chakkalakal SA; Shore EM
    Dis Model Mech; 2012 Nov; 5(6):756-62. PubMed ID: 23115204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Transverse reductional anomaly and atypical fibrodysplasia ossificans progressiva: A case diagnosed late].
    Paysal J; Sarret C; Merlin E; Ravazzolo R; Bocciardi R; Garcier JM; Monnot S; Laffargue F; Baujat G; Echaubard S
    Arch Pediatr; 2017 Jun; 24(6):547-551. PubMed ID: 28416432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Fibrodysplasia Ossificans Progressiva (FOP) mutation p.R206H in ACVR1 confers an altered ligand response.
    Hildebrand L; Stange K; Deichsel A; Gossen M; Seemann P
    Cell Signal; 2017 Jan; 29():23-30. PubMed ID: 27713089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations of the noggin and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP).
    Lucotte G; Lagarde JP;
    Genet Couns; 2007; 18(3):349-52. PubMed ID: 18019378
    [No Abstract]   [Full Text] [Related]  

  • 60. Deregulated bone morphogenetic protein receptor signaling underlies fibrodysplasia ossificans progressiva.
    de Gorter DJ; Jankipersadsing V; Ten Dijke P
    Curr Pharm Des; 2012; 18(27):4087-92. PubMed ID: 22630080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.